The FDA on April 29 issued its long-anticipated final rule amending its regulations to specify that laboratory developed tests (LDTs) are subject to regulation as devices under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Under the final rule, the agency will phase out its multiyear enforcement discretion approach for LDTs so that in vitro diagnostic products (IVD... Read More